Literature DB >> 18486726

Multiple myeloma: detecting the effects of new treatments.

Benjamin Djulbegovic1, Ambuj Kumar.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18486726     DOI： 10.1016/S0140-6736(08)60704-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Efficacy and safety of busulfan-based conditioning regimens for multiple myeloma.

Authors:  Donna Reece; Kevin Song; Richard LeBlanc; Khalid Mezzi; Ade Olujohungbe; Darrell White; Faraz Zaman; Andrew Belch
Journal:  Oncologist       Date:  2013-04-29

2.  Evolution of treatment regimens in multiple myeloma: a social network analysis.

Authors:  Helen Mahony; Athanasios Tsalatsanis; Ambuj Kumar; Benjamin Djulbegovic
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

3.  Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma.

Authors:  Ja Min Byun; Jayoun Lee; Sang-Jin Shin; Minjoo Kang; Sung-Soo Yoon; Youngil Koh
Journal:  Blood Res       Date:  2018-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.